Partnership

As a company focusing on drug discovery and early development, we acknowledge the need for scientific collaboration with academia and co-development with biotechnology and pharmaceutical companies.

Partnering opportunities:
For its own pipeline of products Alligator Bioscience currently seeks partners for two programs:

	ADC-1001, targeting IL-1 for inflammation
	ADC-1004, targeting C5aR for acute inflammations

Collaboration opportunities:
For its proprietary protein optimization technology FIND® Alligator Bioscience seeks collaboration with partners in need of superior protein biopharmaceuticals.

Over the years Alligator Bioscience has collaborated with the following disclosed business partners:

AstraZeneca
AxisShield ASA
Bayer Schering Pharma
Enzymes/Roal
HemoCue AB
ImmuRx
Wyeth Pharmaceuticals

Lars Örning, Axis-Shield PoC
"Axis-Shield has been collaborating with Alligator on and off since 2002. The collaborations have been successful and we have always found Alligator highly experienced, reliable, and generally easy to deal with."

David Delucia, CEO, ImmuRx
“Alligator has provided good science, excellent communication and strong project management to our program. We have been pleased to have them as a strategic partner.”